In experimental MASLD models, turmeric’s curcumin polyphenol has been demonstrated to decrease inflammation and hepatic steatosis by activating AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma (PPARγ), two crucial regulators of energy balance and lipid metabolism (7). This evidence concerns the gene PRKAA1 and fatty liver disease.